2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epilepti

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514319, 514423, 514428, 514624, 514626, 544165, 546205, 548537, 548568, 564190, 564194, C07D29514, A61K 31535

Patent

active

048732419

ABSTRACT:
2-Amino-N-(2-phenylindan-2-yl)acetamides of the following formula are provided ##STR1## wherein, a=0 to 3,

REFERENCES:
patent: 3408389 (1968-10-01), Bernstein et al.
patent: 3923813 (1975-12-01), Vanhoof et al.
patent: 3923815 (1975-12-01), Vanhoof et al.
patent: 3923887 (1975-12-01), Vanhoof et al.
patent: 4304785 (1981-12-01), Griengl et al.
patent: 4602035 (1986-07-01), Tegeler et al.
Dai-Ho et al., Tet. Lett. 26, 5867-70 (1985).
Sofroniev et al., Dokl. Bolg. Akad. Nauk., 34, 1269-72 (1981).
Minchev et al., Dokl. Bolg. Akad. Nauk., 34, 1111-14 (1981).
Chem. Abstract 64:19517c, abstracting Netherlands Patent Application 6,509,640.
Alesiev et al., J. Prak. Chem., 316, 140-6 (1974).
Minchev et al., Symp. Pap.-IUPAC Int. Sump. Chem. Nat. Products, 11th, 3, 174-7 (1978).
Heymans et al., J. Med. Chem., 23, 184-193 (1980).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epilepti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epilepti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epilepti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1957857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.